Trials / Conditions / Metastatic Pancreatic Carcinoma

Metastatic Pancreatic Carcinoma

20 registered clinical trials studyying Metastatic Pancreatic Carcinoma — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced NCT06906562	Sameek Roychowdhury	Phase 2
Recruiting	HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients NCT06770452	Zhejiang University	Phase 2
Not Yet Recruiting	Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer NCT06759090	Zhejiang University	Phase 2
Recruiting	Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis NCT04858009	Mayo Clinic	Phase 2
Recruiting	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati NCT05733000	Northwestern University	Phase 2
Recruiting	First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patien NCT05759923	Molecure S.A.	Phase 1
Active Not Recruiting	Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) NCT05642962	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2
Recruiting	Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors NCT05053971	National Cancer Institute (NCI)	Phase 1 / Phase 2
Active Not Recruiting	Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fa NCT04673448	University of Washington	Phase 1
Active Not Recruiting	Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events NCT05038254	M.D. Anderson Cancer Center	N/A
Recruiting	Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations NCT04550494	National Cancer Institute (NCI)	Phase 2
Terminated	Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutat NCT04390243	Academic and Community Cancer Research United	Phase 2
Terminated	Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver NCT03818165	Sorrento Therapeutics, Inc.	Phase 1
Recruiting	Intravital Microscopy in Human Solid Tumors NCT03823144	Mayo Clinic	N/A
Active Not Recruiting	Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer NCT03825289	University of Utah	Phase 1
Completed	Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors o NCT03033225	Mayo Clinic	Phase 2
Active Not Recruiting	M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Rem NCT02595931	National Cancer Institute (NCI)	Phase 1
Completed	A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer NCT00480584	H. Lee Moffitt Cancer Center and Research Institute	Phase 1
Terminated	A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral NCT00843830	University of Michigan Rogel Cancer Center	Phase 1
Completed	Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer NCT00137761	Dana-Farber Cancer Institute	Phase 2